Glaucoma Therapy – Current Overview of Data and Information
Authors:
P. Výborný 1; S. Sičáková 1; P. Dohnalová 1; M. Feřtek 2; T. Doležal 3
Authors‘ workplace:
Oční klinika 1. LF UK a ÚVN – Vojenská fakultní nemocnice, Praha, přednosta doc. MUDr. Jiří Pašta, CSc., FEBO
1; Státní ústav kontroly léčiv, Praha, ředitel MUDr. Pavel Březovský, MBA
2; Institut pro zdravotní ekonomiku, Farmakologický ústav 2. LF UK, Praha, přednosta MUDr. Martin Votava, PhD.
3
Published in:
Čes. a slov. Oftal., 69, 2013, No. 3, p. 118-126
Category:
Original Article
Overview
The authors submit the overview of the actual situation in the glaucoma therapy. They follow up the trends in antiglaucomatic treatment in the last period including financial aspects of medicament and surgical treatment. Attention is paid especially to medicaments management, actual overview of available antiglaucomatic drugs, function and position of generic drugs and differences among them, the daily dose of benzalconium chloride in glaucoma treatment, actual average of patients’ supplementary payments at the drug purchase in the pharmacy, surgical treatment costs and legal issues. Pharmacologist’s viewpoints and the Czech State Drug Control Authority (SÚKL) opinions complete the professional’s point of the view and facilitate his/her complete orientation in glaucoma therapy issues.
Key words:
glaucoma, prescription, surgical treatment, treatment costs, legal issues
Sources
1. Daull, P, Garriguie, J.S.: Preservative-free cationic nano emulsion of latanoprost. Ophthalmology Times Europe, Jan/Feb 2013: 8–10.
2. Doležal, T.: Od molekuly k dlouhodobé spokojenosti pacienta. Farmakoterapie, 2; 6, 2012: 4–6.
3. Herndon, L.W, Asrani, S.G., Williams, G. H. et al.: Paradoxial intraocular pressure elevation after combined therapy with latanoprost and bimatoprost. Arch Ophthalmol, 120; 2002: 847–849.
4. IMS Health – analytická společnost, Praha, Dataview 2010–2012.
5. Liang, H., Baudoin, P., Daull, P. et al: In vitro and in vivo evaluation of preservative-free cationic emulsion of latanoprost in cornal wound healing. Cornea, 31; 2012: 1319–1329.
6. Prokeš, M.: Prekripční a indikační omezení pro léky v České republice. Farmakoekonomika, 6; 2012: 2–6.
7. Výborný, P., Sejčková, L.: Antiglaukomatika – obsah konzervačních látek a spolupráce pacienta v léčebném režimu. Čes a Slov Oftal, 62; 2006: 270–274.
8. Výborný, P., Dohnalová, P., Sičáková, S.: Antiglaukomatika v číslech a tabulkách – trendy v preskripci. In Trendy soudobé oftalmologie, svazek 8, Ed. Rozsíval P., Praha, Galén 2012, 247–255.
9. Výborný, P., Fučík, M., Rozsíval, P.: Glaukom. In. Kuchynka P. et al. Oční lékařství, Praha, Grada 2007, 596–607.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2013 Issue 3
Most read in this issue
- Glaucoma Therapy – Current Overview of Data and Information
- New Methods of the Treatment of Retinal Dystrophies
- The Potential use of Honey in Ophthalmology
- Surgical Treatment of the Idiopatic Macular Hole – our Experience